Epithelial ovarian cancer (EOC) is the deadliest gynecologic cancer. Recently, the existence of ovarian cancer stem cells has been reported. Sox2, Nanog and Oct4 are key markers of “stemness”. The objective of this study was to determine whether Sox2, Nanog, and Oct4 are associated with EOC and poor outcome. The expression of these markers was assessed by immunofluorescence staining and real-time RT-PCR in human EOC cell lines MDAH-2774 and SKOV-3, while the cancer genome atlas (TCGA) dataset was analyzed for associations with survival. Sox2, Nanog and Oct4 (POU5F1) were all detected by immunofluorescence staining and these results were confirmed by real-time RT-PCR. The TCGA dataset revealed a 26%, 9%, and 6% amplification of Sox2, Nanog and POU5F1, respectively. Additionally, K-M survival analyses showed a significant median overall survival difference (41 versus 48.3 months, P = .01) for Sox2 amplification, but not for Nanog (44.1 versus 36.2 months, P > .05) and POU5F1 (43.5 versus 45.0 months, P > .05). Our results suggest that Sox2 gene amplification significantly influences overall survival.
MinegishiKTanakaMNishimuraO. Reactive oxygen species mediate leukocyte-endothelium interactions in prostaglandin F2alpha-induced luteolysis in rats. Am J Physiol Endocrinol Metab. 2002;283(6):E1308–E1315.
9.
ShiraiFKawaguchiMYutsudoMDohiY. Human peripheral blood polymorphonuclear leukocytes at the ovulatory period are in an activated state. Mol Cell Endocrinol. 2002;196(1-2):21–28.
10.
BehrmanHRKodamanPHPrestonSLGaoS. Oxidative stress and the ovary. J Soc Gynecol Investig. 2001;8(1 suppl proceedings):S40–S42.
11.
GuoRWuQLiuFWangY. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Oncol Rep. 2011;25(1):141–146.
12.
HussenetTDaliSExingerJ. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One. 2010;5(1):e8960.
13.
KatohMKatohM.Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. Int J Oncol. 2007;31(2):461–466.
14.
LuYFuttnerCRockJR. Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One. 2010;5(6):e11022.
15.
TaniYAkiyamaYFukamachiHYanagiharaKYuasaY. Transcription factor SOX2 up-regulates stomach-specific pepsinogen a gene expression. J Cancer Res Clin Oncol. 2007;133(4):263–269.
16.
ZhongXLiNLiangSHuangQCoukosGZhangL. Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J Biol Chem. 2010;285(53):41961–41971.
17.
ZhangSBalchCChanMW. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68(11):4311–4320.
18.
ReyaTMorrisonSJClarkeMFWeissmanIL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111.
19.
BonnetDDickJE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–737.
20.
SinghSKClarkeIDTerasakiM. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821–5828.
21.
Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100(7):3983–3988.
22.
O'BrienCAPollettAGallingerSDickJE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106–110.
23.
LiCHeidtDGDalerbaP. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030–1037.
24.
ThomsonJAItskovitz-EldorJShapiroSS. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–1147.
25.
CasatiAFrascoliMTraggiaiEProiettiMSchenkUGrassiF. Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP. Cell Death Differ. 2011;18(3):396–404.
26.
AbdelalimEMTooyamaI. NPR-A regulates self-renewal and pluripotency of embryonic stem cells. Cell Death Dis. 2011;2:e127.
27.
RichlyHAloiaLDi CroceL. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2011;2:e204.
28.
ChambersIColbyDRobertsonM. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113(5):643–655.
TakahashiKTanabeKOhnukiM. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872.
31.
TakahashiKYamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676.
32.
Varnum-FinneyBXuLBrashem-SteinC. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med. 2000;6(11):1278–1281.
33.
KaranuFNMurdochBGallacherL. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med. 2000;192(9):1365–1372.
34.
BhardwajGMurdochBWuD. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol. 2001;2(2):172–180.
35.
NusseRVarmusHE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982;31(1):99–109.
36.
CadiganKMNusseR. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11(24):3286–3305.
37.
ReyaTO'RiordanMOkamuraR. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity. 2000;13(1):15–24.
38.
AustinTWSolarGPZieglerFCLiemLMatthewsW. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood. 1997;89(10):3624–3635.
39.
Van Den BergDJSharmaAKBrunoEHoffmanR. Role of members of the Wnt gene family in human hematopoiesis. Blood. 1998;92(9):3189–3202.
40.
DaheronLOpitzSLZaehresH. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells. 2004;22(5):770–778.
41.
IvanovaNBDimosJTSchanielCHackneyJAMooreKALemischkaIR. A stem cell molecular signature. Science. 2002;298(5593):601–604.
42.
Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–615.
43.
Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–1068.
44.
VerhaakRGHoadleyKAPurdomE. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.
45.
WangXVVerhaakRGPurdomESpellmanPTSpeedTP. Unifying gene expression measures from multiple platforms using factor analysis. PLoS One. 2011;6(3):e17691.
GaoJAksoyBADogrusozU. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.
48.
SebatJLakshmiBTrogeJ. Large-scale copy number polymorphism in the human genome. Science. 2004;305(5683):525–528.
49.
IafrateAJFeukLRiveraMN. Detection of large-scale variation in the human genome. Nat Genet. 2004;36(9):949–951.
50.
RedonRIshikawaSFitchKR. Global variation in copy number in the human genome. Nature. 2006;444(7118):444–454.
51.
WongKKdeLeeuwRJDosanjhNS. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet. 2007;80(1):91–104.
52.
NiwaHOgawaKShimosatoDAdachiK. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature. 2009;460(7251):118–122.
53.
MaLLaiDLiuTChengWGuoL. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin (Shanghai). 2010;42(9):593–602.
54.
GontanCde MunckAVermeijMGrosveldFTibboelDRottierR. Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol. 2008;317(1):296–309.
55.
ZhangJChangDYMercado-UribeILiuJ. Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma. Hum Pathol. 2012;43(9):1405–1412.
56.
YeFLiYHuYZhouCHuYChenH. Expression of Sox2 in human ovarian epithelial carcinoma. J Cancer Res Clin Oncol. 2011;137(1):131–137.
57.
PengSMaihleNJHuangY. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene. 2010;29(14):2153–2159.
58.
MakVCSiuMKWongOGChanKKNganHYCheungAN. Dysregulated stemness-related genes in gynecological malignancies. Histol Histopathol. 2012;27(9):1121–1130.
59.
LiangDMaYLiuJ. The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells. BMC Cancer. 2012;12:201.
60.
KregelSKirilukKJRosenAM. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One. 2013;8(1):e53701.
61.
GubbayJCollignonJKoopmanP. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature. 1990;346(6281):245–250.
62.
BowlesJSchepersGKoopmanP. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000;227(2):239–255.
WegnerM. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999;27(6):1409–1420.
65.
SoullierSJayPPoulatFVanackerJMBertaPLaudetV. Diversification pattern of the HMG and SOX family members during evolution. J Mol Evol. 1999;48(5):517–527.
66.
RizzinoA. Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells. Wiley Interdiscip Rev Syst Biol Med. 2009;1(2):228–236.
67.
JohanssonHSimonssonS.Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination. Aging (Albany NY). 2010;2(11):815–822.
68.
ZhangXLuFWangJ. Pluripotent stem cell protein Sox2 confers sensitivity to LSD1 inhibition in cancer cells. Cell Rep. 2013;5(2):445–457.
69.
VelchetiVSchalperKYaoX. High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One. 2013;8(4):e61427.
70.
WilbertzTWagnerPPetersenK. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol. 2011;24(7):944–953.
71.
AbbasHAPantVLozanoG. The ups and downs of p53 regulation in hematopoietic stem cells. Cell Cycle. 2011;10(19):3257–3262.
72.
LinTChaoCSaitoS. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol. 2005;7(2):165–171.
73.
XuY. A new role for p53 in maintaining genetic stability in embryonic stem cells. Cell Cycle. 2005;4(3):363–364.
74.
BoydJSonodaYFedericiMG. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000;283(17):2260–2265.
75.
GargKLevineDAOlveraN. BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas. Am J Surg Pathol. 2013;37(1):138–146.
76.
LacourRAWestinSNMeyerLA. Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecol Oncol. 2011;121(2):358–363.
77.
LiuJCristeaMCFrankelP. Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival. Cancer Genet. 2012;205(1-2):34–41.
78.
LiuGYangDSunY. Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer. Pharmacogenomics. 2012;13(13):1523–1535.
